- en: <!--yml
  id: totrans-split-0
  prefs: []
  type: TYPE_NORMAL
  zh: <!--yml
- en: 'category: 未分类'
  id: totrans-split-1
  prefs: []
  type: TYPE_NORMAL
  zh: 'category: 未分类'
- en: 'date: 2024-05-27 14:33:39'
  id: totrans-split-2
  prefs: []
  type: TYPE_NORMAL
  zh: 'date: 2024-05-27 14:33:39'
- en: -->
  id: totrans-split-3
  prefs: []
  type: TYPE_NORMAL
  zh: -->
- en: Researchers Uncover Potential Non-Opioid Treatment for Chronic Pain - UT News
  id: totrans-split-4
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 研究人员发现潜在的非阿片类治疗慢性疼痛方法 - 德克萨斯大学新闻
- en: 来源：[https://news.utexas.edu/2024/01/30/researchers-uncover-potential-non-opioid-treatment-for-chronic-pain/](https://news.utexas.edu/2024/01/30/researchers-uncover-potential-non-opioid-treatment-for-chronic-pain/)
  id: totrans-split-5
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 来源：[https://news.utexas.edu/2024/01/30/researchers-uncover-potential-non-opioid-treatment-for-chronic-pain/](https://news.utexas.edu/2024/01/30/researchers-uncover-potential-non-opioid-treatment-for-chronic-pain/)
- en: A new approach to treating neuropathic pain is making a key step forward thanks
    to researchers at The University of Texas at Austin.
  id: totrans-split-6
  prefs: []
  type: TYPE_NORMAL
  zh: 一种新的治疗神经病性疼痛的方法正在往前迈出关键一步，这要归功于德克萨斯大学奥斯汀分校的研究人员。
- en: Among the most difficult types of pain to alleviate is neuropathic pain, pain
    that is usually caused by damage to nerves in various body tissues, including
    skin, muscle and joints. It can cause patients to suffer feelings like electric
    shocks, tingling, burning or stabbing. Diabetes, multiple sclerosis, chemotherapy
    drugs, injuries and amputations have all been associated with neuropathic pain,
    which is often chronic, sometimes unrelenting and affects millions of people worldwide.
    Many of the available pain medications are only moderately effective at treating
    this type of pain and often come with serious side effects, as well as risk of
    addiction.
  id: totrans-split-7
  prefs: []
  type: TYPE_NORMAL
  zh: 在最难以缓解的疼痛类型中，神经病性疼痛是其中之一，通常是由于各种身体组织中的神经损伤引起，包括皮肤、肌肉和关节。它可以导致患者感受到像电击、刺痛、灼热或刺扎等感觉。糖尿病、多发性硬化症、化疗药物、伤害和截肢等都与神经病性疼痛有关，这种疼痛通常是慢性的，有时无法缓解，影响全球数百万人。许多现有的止痛药物在治疗这种类型的疼痛时只能起到中度作用，并且常伴有严重的副作用，以及成瘾的风险。
- en: Now researchers at UT Austin, The University of Texas at Dallas and the University
    of Miami have identified a molecule that reduces hypersensitivity in trials in
    mice by binding to a protein they have shown is involved in neuropathic pain.
  id: totrans-split-8
  prefs: []
  type: TYPE_NORMAL
  zh: 现在，德克萨斯大学奥斯汀分校、德克萨斯大学达拉斯分校和迈阿密大学的研究人员已经确定了一种分子，在小鼠试验中通过与一种已显示参与神经病性疼痛的蛋白质结合来减少过敏反应。
- en: The findings appear in the journal *[Proceedings of the National Academy of
    Sciences](https://doi.org/10.1073/pnas.2306090120)*.
  id: totrans-split-9
  prefs: []
  type: TYPE_NORMAL
  zh: 这些发现发表在期刊 *[美国国家科学院院刊](https://doi.org/10.1073/pnas.2306090120)* 中。
- en: “We found it to be an effective painkiller, and the effects were rather long-lived,”
    said Stephen Martin, the June and J. Virgil Waggoner Regents Chair in Chemistry
    at The University of Texas at Austin and co-corresponding author of the paper.
    “When we tested it on different models, diabetic neuropathy and chemotherapy-induced
    neuropathy, for example, we found this compound has an incredible beneficial effect.”
  id: totrans-split-10
  prefs: []
  type: TYPE_NORMAL
  zh: “我们发现它是一种有效的止痛药，效果相当持久，”德克萨斯大学奥斯汀分校化学系6月和J. Virgil Waggoner Regents主席以及本文的共同通讯作者史蒂芬·马丁（Stephen
    Martin）说道。“当我们在不同的模型上进行测试时，例如糖尿病性神经病和化疗引起的神经病时，我们发现这种化合物具有令人难以置信的益处。”
- en: The new compound, dubbed FEM-1689, does not engage opioid receptors in the body,
    making it a possible alternative to existing pain medications linked to addiction.
    In addition to reducing sensitivity, the compound can help regulate the integrated
    stress response (ISR), a network of cellular signaling that helps the body respond
    to injuries and diseases. When well regulated, the ISR restores balance and promotes
    healing. When it goes awry, the ISR can contribute to diseases such as cancer,
    diabetes and metabolic disorders.
  id: totrans-split-11
  prefs: []
  type: TYPE_NORMAL
  zh: 这种新化合物，被称为FEM-1689，不会与体内的阿片受体结合，因此可能成为与成瘾有关的现有止痛药物的替代品。除了减少敏感性外，这种化合物还可以帮助调节综合应激反应（ISR），这是一种细胞信号网络，帮助身体应对损伤和疾病。当ISR得到良好调节时，它能恢复平衡并促进愈合。但当ISR出现问题时，可能会导致癌症、糖尿病和代谢性疾病等疾病的发生。
- en: “It’s our goal to make this compound into a drug that can be used to treat chronic
    pain without the dangers of opioids,” Martin said. “Neuropathic pain is often
    a debilitating condition that can affect people their entire lives, and we need
    a treatment that is well tolerated and effective.”
  id: totrans-split-12
  prefs: []
  type: TYPE_NORMAL
  zh: “我们的目标是将这种化合物制成一种药物，可以用于治疗慢性疼痛，而不会带来阿片类药物的危险，”马丁说道。“神经病性疼痛通常是一种让人无法忍受的状况，可能会影响人的整个生命，我们需要一种既能耐受又有效的治疗方法。”
- en: NuvoNuro Inc., a company co-founded by Martin and other authors on the paper,
    was recently awarded a grant from the National Institutes of Health HEAL Initiative,
    which funds research to find scientific solutions to the national opioid crisis,
    to create a drug based on their findings.
  id: totrans-split-13
  prefs: []
  type: TYPE_NORMAL
  zh: 由马丁和本文其他作者共同创立的公司NuvoNuro Inc.最近获得了国家卫生研究院（NIH）HEAL计划的资助，该计划旨在通过资助研究找到科学解决方案来解决全国阿片类药物危机问题，以基于他们的研究成果开发药物。
- en: “This work is the culmination of a wonderful five-year collaboration with our
    colleagues at UT Austin and is a great example of academic drug discovery pushing
    the field of non-opioid pain therapeutics forward,” said Theodore Price, a professor
    of neuroscience at The University of Texas at Dallas and co-corresponding author
    of the paper. “Our funding from NIH on this continuing project through our spin-out
    company, NuvoNuro, has the potential to take us toward clinical development in
    the next few years, which is extraordinarily exciting.”
  id: totrans-split-14
  prefs: []
  type: TYPE_NORMAL
  zh: “这项工作是与我们在德克萨斯大学奥斯汀分校的同事进行了五年美好合作的结晶，是学术药物发现推动非阿片类疼痛治疗领域前进的一个很好的例子，” 达拉斯德克萨斯大学神经科学教授、本文的共同通讯作者西奥多·普赖斯说道。“我们从国家卫生研究院（NIH）获得的资金支持，通过我们的分拆公司NuvoNuro在这一持续项目上的资金有望在未来几年内进入临床开发阶段，这非常令人兴奋。”
- en: Muhammad Saad Yousuf, Eric T. David, Stephanie Shiers, Marisol Mancilla Moreno,
    Jonathan Iketem, Danielle M. Royer, Chelsea D. Garcia, Jennifer Zhang, Veronica
    M. Hong, Subhaan M. Mian, Ayesha Ahmad and Benedict J. Kolber of The University
    of Texas at Dallas;  James J. Sahn and Hongfen Yang of UT Austin; and Daniel J.
    Liebl of University of Miami Miller School of Medicine were also authors on the
    paper.
  id: totrans-split-15
  prefs: []
  type: TYPE_NORMAL
  zh: 德克萨斯大学达拉斯分校的穆罕默德·萨义德·尤苏夫、埃里克·T·大卫、斯蒂芬妮·希尔斯、玛丽索尔·曼西亚·莫雷诺、乔纳森·伊凯特姆、丹妮尔·M·罗耶、切尔西·D·加西亚、詹妮弗·张、维罗尼卡·M·洪、苏哈恩·M·米安、艾莎·艾哈迈德和本尼迪克特·J·科尔伯，德克萨斯大学奥斯汀分校的詹姆斯·J·萨恩和杨洪芬，以及迈阿密大学米勒医学院的丹尼尔·J·利布尔也是本文的作者。
- en: The research was funded by the National Institutes of Health, Natural Sciences
    and Engineering Research Council of Canada and the Robert A. Welch Foundation.
  id: totrans-split-16
  prefs: []
  type: TYPE_NORMAL
  zh: 这项研究得到了国家卫生研究院、加拿大自然科学和工程研究理事会以及罗伯特·A·韦尔奇基金会的资助。
- en: '*The University of Texas at Austin is committed to transparency and disclosure
    of all potential conflicts of interest. University investigators involved in this
    research have submitted required financial disclosure forms with the University.
    As co-founders of NuvoNuro Inc., Stephen Martin and James Sahn also are co-inventors
    on patents and pending patent applications related to work described in this article.*'
  id: totrans-split-17
  prefs: []
  type: TYPE_NORMAL
  zh: '*德克萨斯大学奥斯汀分校致力于透明和披露所有潜在利益冲突。参与本研究的大学调查人员已向大学提交了必需的财务披露表格。作为NuvoNuro Inc.的联合创始人，斯蒂芬·马丁和詹姆斯·萨恩也是本文描述的工作相关专利和待审专利申请的共同发明人。*'
